Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Peptide Therapeutics Market to Grow at a CAGR of 7.6% During 2022-2027, Aided by the Thriving Pharmaceutical and Healthcare Sectors

According to a new report by EMR titled, ‘Global Peptide Therapeutics Market Report and Forecast 2022-2027’, the market attained a value of nearly USD 33.58 billion in 2021. The market is further expected to grow at a CAGR of 7.6% between 2022 and 2027 to reach USD 52.26 billion by 2027.

The market for peptide therapeutics is driven by the thriving pharmaceutical and healthcare sectors, especially in emerging economies. In addition to this, the greater access to medical facilities and the increased availability of biosimilars are anticipated to be the major drivers for the market. Moreover, the growing awareness about different oral peptide therapeutic treatments with fewer side-effects is anticipated to fuel the market growth in the forecast period.

The market players are increasingly investing in research and development activities to develop novel solutions, which, in turn, is leading to increased collaborations. For instance, in December 2020, Takeda Pharmaceutical Co Ltd. announced a collaborative research and exclusive license agreement with Peptidream Inc. This collaborative agreement was aimed towards creating peptide drug conjugates (PDCs) for neuromuscular diseases. Some of the leading players in the market include Pfizer Inc. (NYSE: PFE) and AstraZeneca plc (NASDAQ: AZN).

In terms of region, North America is likely to account for a significant share of the market and is anticipated to witness a considerable growth in the forecast period. The United States of America significantly spends on its healthcare services and infrastructure. The superior medical facilities, along with the rising public expenditure on health, is anticipated to favour the market growth in the region.

Market Breakup by Marketing Type, Application, Route of Administration, and Region:

  • The market is bifurcated based on marketing type into generic and branded.
  • Based on application, the market is divided into gastrointestinal disorders, neurological disorders, metabolic disorders, cancer, and cardiovascular, among others.
  • On the basis of route of administration, the market is divided into parenteral, and oral, among others.
  • Region-wise, the global market for peptide therapeutics can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The global market for peptide therapeutics is being driven by the growing cases of chronic diseases and increasing cases of cancer.
  • The increasing investments towards the development of biosimilars are anticipated to boost the market growth.
  • In addition to this, the expansion of the healthcare sector, especially in emerging economies, is likely to provide impetus to the market.
  • The market is further expected to be aided by the rapid advancements in the biotechnology and biopharmaceutical sectors.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for peptide therapeutics for the periods (2017-2021) and (2022-2027).
  • The report also offers historical (2017-2021) and forecast (2022-2027) market information for the marketing types, applications, routes of administration, and regions of peptide therapeutics.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global peptide therapeutics market are Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Amgen Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER